247 related articles for article (PubMed ID: 25875115)
1. Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.
Gao Y; Su Q; Yi Y; Jia Z; Wang H; Lu X; Qiu F; Bi S
PLoS One; 2015; 10(4):e0123400. PubMed ID: 25875115
[TBL] [Abstract][Full Text] [Related]
2. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
[TBL] [Abstract][Full Text] [Related]
3. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
Dong C; Dai X; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
[TBL] [Abstract][Full Text] [Related]
4. The expression, purification, and immunogenicity of a new chimeric virus-like particle.
Kui X; Sun M; Xie T; Wang W; Jiang L; Yan M; Ma K; Li H
Viral Immunol; 2009 Feb; 22(1):49-56. PubMed ID: 19210228
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice.
Gao S; Li D; Liu Y; Zha E; Zhou T; Yue X
Int Immunopharmacol; 2015 Jan; 24(1):140-5. PubMed ID: 25445956
[TBL] [Abstract][Full Text] [Related]
6. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
Dong C; Dai X; Meng JH
Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
8. N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice.
Tao W; Zheng HQ; Fu T; He ZJ; Hong Y
Hum Vaccin Immunother; 2017 Aug; 13(8):1818-1822. PubMed ID: 28604244
[TBL] [Abstract][Full Text] [Related]
9. Specific memory B cell response and participation of CD4
Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS
Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
12. Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants.
Joshi SS; Arankalle VA
Viral Immunol; 2016; 29(6):350-60. PubMed ID: 27285290
[TBL] [Abstract][Full Text] [Related]
13. Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein VP1 for developing subunit vaccine material against hepatitis A virus.
Jang KO; Park JH; Lee HH; Chung DK; Kim W; Chung IS
Protein Expr Purif; 2014 Aug; 100():1-9. PubMed ID: 24816194
[TBL] [Abstract][Full Text] [Related]
14. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
Zhou YH; Purcell RH; Emerson SU
Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S
Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.
Khateri M; Abdoli A; Motevalli F; Fotouhi F; Bolhassani A; Arashkia A; Jazaeri EO; Shahbazi S; Mehrbod P; Naziri H; Aghasadeghi MR
IUBMB Life; 2018 Mar; 70(3):207-214. PubMed ID: 29369472
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
20. Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study.
Ye C; Luo J; Wang X; Xi J; Pan Y; Chen J; Yang X; Li G; Sun Q; Yang J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2165-2170. PubMed ID: 28631170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
